Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). (Q52147927)
Jump to navigation
Jump to search
scientific article published on 13 October 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). |
scientific article published on 13 October 2015 |
Statements
1 reference
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). (English)
1 reference
1 reference
1 reference
1 reference
1 reference
S Mathoulin-Pélissier
1 reference
M Untch
1 reference
S Delaloge
1 reference
S Gourgou-Bourgade
1 reference
D Cameron
1 reference
P Poortmans
1 reference
B Asselain
1 reference
D Azria
1 reference
R A'Hern
1 reference
J Bliss
1 reference
J Bogaerts
1 reference
H Bonnefoi
1 reference
E Brain
1 reference
M J Cardoso
1 reference
B Chibaudel
1 reference
R Coleman
1 reference
T Cufer
1 reference
L Dal Lago
1 reference
F Dalenc
1 reference
M Debled
1 reference
T Filleron
1 reference
J Gligorov
1 reference
M Gutowski
1 reference
W Jacot
1 reference
C Kirkove
1 reference
G MacGrogan
1 reference
I Negreiros
1 reference
B V Offersen
1 reference
F Penault Llorca
1 reference
G Pruneri
1 reference
H Roche
1 reference
N S Russell
1 reference
V Servent
1 reference
B Thürlimann
1 reference
J A van der Hage
1 reference
G van Tienhoven
1 reference
H Wildiers
1 reference
J Yarnold
1 reference
F Bonnetain
1 reference
T S Dabakuyo-Yonli
1 reference
13 October 2015
1 reference
1 reference
26
1 reference
12
1 reference
2505-2506
1 reference
Identifiers
1 reference
1 reference